Why the study?
It was unknown whether resting levels and exercise-induced changes in cTnT, NT-proBNP, and prothrombotic markers during exercise ECG stress testing are affected by revascularization in CAD patients.
Does revascularization reduce resting levels and exercise-induced changes in cardiac and prothrombotic biomarkers in patients with coronary artery disease?
Does revascularization reduce resting levels and exercise-induced changes in cardiac and prothrombotic biomarkers in patients with coronary artery disease?
Revascularization in CAD patients does not prevent the exercise-induced secretion of cardiac and prothrombotic biomarkers, though it may reduce resting thrombin generation and endothelial activation.
Revascularization does not blunt exercise-induced biomarker rises in CAD; leaves open effects on clinical events and needs larger trials.
We examined whether resting levels and exercise-induced changes during exercise ECG stress test (EST) of cardiac Troponin T (cTnT), NT-proBNP and prothrombotic markers were affected by revascularization in patients with coronary artery disease (CAD). EST1 was performed before coronary angiography and revascularization, and patients (n = 20) with confirmed CAD, performed another EST (EST2) 9 weeks later. Blood samples were drawn at rest and within five min after termination of ESTs. cTnT and NT-proBNP increased during exercise at both ESTs (p < 0.001, all). Resting cTnT levels at EST2 versus EST1 were significantly higher (p = 0.02) whereas NT-proBNP did not differ. At both visits, increased D-dimer (p = 0.008 and <0.001), pro-thrombin fragment 1 + 2 (p = 0.009 and 0.001) and tissue factor pathway inhibitor (TFPI) (p < 0.001 and 0.001) during exercise were demonstrated. Resting levels of endogenous thrombin potential (ETP) and TFPI were reduced at EST2 versus EST1 (p < 0.01). Revascularization did not affect exercise-induced release of cardiac and prothrombotic biomarkers and did not reduce resting levels of cTnT or NT-proBNP, suggesting revascularization per se not to prevent secretion of biomarkers. The lower resting levels of ETP and TFPI after revascularization may however, be indicative of reduced thrombin generation and endothelial activation. Clinicaltrials.gov, CADENCE, NCT01495091 https://clinicaltrials.gov/ct2/show/NCT01495091?term = 01495091&draw = 2&rank = 1 .
No takes yet. Share an insight, caveat, or question.
Hansen et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: